High-throughput mass screening platform to spur drug development in breast cancer by testing response to over 100 anti-cancer agents as monotherapy or in combination. Response to therapy validated in ...
Read moreResearchers at the Institute of Biomedical Research of Bellvitge (IDIBELL), led by Dr. Eva Gonzalez-Suarez, have shown that pharmacological and genetic inhibition of signaling pathway RANK / RANKL lea...
Read moreVarious research lines led by VHIO aim at better deciphering how tumor cells acquire resistance to anticancer agents including palbociclib and treatments inducing DNA damage. The expression of partial...
Read moreResearchers at the Centre for Genomic Regulation describe a repression mechanism active in hormone-dependent breast cancer cells for the first time. The repression complex of these cells silences gene...
Read moreFindings show that the genomic classification of tumors — the molecular subtyping of primary tumors, can predict the evolution of patients from the onset of metastasis and that this cancer intrinsic...
Read moreIn an article published in Nature Communications, scientists at IRB Barcelona reveal that breast cancer cells require fatty acids from the extracellular environment in order to continue proliferating....
Read moreProspective Clinical Study Showed the myRisk Test Identified 70 Percent More Deleterious Mutations than BRCA Testing Alone with 42 Percent of These in Women Over Age 45.
Read moreResearchers have shown that the biology identified with genomic data is the most significant predictor of treatment response and survival beyond the 4-5 variables that are currently used in clinical p...
Read moreResearch at VHIO has for the first time evidenced the clinical utility of mass spectrometry in formalin-fixed, paraffin-embedded breast cancer tissue samples. VHIO researchers have shown the quantific...
Read moreA study published in the Journal of National Cancer Institute (JNCI) by ICREA researcher Roger Gomis may be key to the early detection of patients at risk of developing metastasis to the bone. This ne...
Read moreMost European countries acknowledge the importance of quality in breast cancer services but use different standards to cover the various stages of care
Read moreEl Institut de Recerca de Sant Pau pone en marcha un estudio europeo para cuantificar el coste socioeconómico del cáncer de mama
Read more